ANDA 201511, held by Ph Health. Mafenide Acetate.
As of Nov 16, 2026, ANDA 201511 (Mafenide Acetate), held by Ph Health, was first approved by FDA on Feb 12, 2013, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 12, 2013 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Mafenide Acetate5% ยท for solution;topical | Mafenide Acetate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters